Clinical Trial Update: A Study of Axitinib in Patients With Advanced Angiosarcoma and Other Soft Tissue Sarcomas [Phase 2]

View source ↗

Summary

Phase 2 trial update for axitinib in advanced angiosarcoma and other soft tissue sarcomas has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angiosarcoma
• Soft Tissue Sarcoma

Drugs mentioned

• Axitinib (Axitinib)

Snippet

Sponsor: Sheffield Teaching Hospitals NHS Foundation Trust | Conditions: Soft Tissue Sarcoma | Phase 2 | Status: COMPLETED